JPRN-UMIN000005548招募中1 期
eoadjuvant Chemotherapy for HER2-positive Stage IV advanced gastric cancer with S-1/Cisplatin/Trastuzumab - Neoadjuvant Chemotherapy for HER2-positive advanced gastric cancer with S-1/Cisplatin/Trastuzumab
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Malignant tumor of other organs 2. Severe medical condition 3. Active bleeding from gastrointestinal tract 4. Poor oral intake 5. Contraindication for S-1, Cisplatin or Trastuzumab
研究者
相似试验
尚未招募
不适用
De-escalation of adjuvant chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer subjects who achieved pathological complete response after neoadjuvant chemotherapy and dual HER2-blockadeKCT0007645Korean Cancer Study Group1,065
进行中（未招募）
1 期
Clinical study to test a new treatment regimen without chemotherapy after surgery for patients with early breast cancer that is ‘HER2-positive’ and ‘hormone receptor-negative’, who respond well to a simplified pre-surgery treatment.HER2-positive, estrogen receptor (ER)-negative/progesterone receptor (PR)-negative, node-negative early breast cancerEUCTR2020-002918-41-ITInstitut Jules Bordet1,065
已完成
2 期
FT monotherapy as adjuvant chemotherapy for HER2 negative breast cancer patients who did not achieve pathologic complete response (non-pCR) after neoadjuvant chemotherapy: Phase 2 study.Breast cancerJPRN-UMIN000003835Osaka Medical College Hospital50
进行中（未招募）
1 期
PREDIX HER2 - preoperative treatment of HER2 positive breast cancerPrimary breast cancerMedDRA version: 20.0Level: PTClassification code: 10006201Term: Breast cancer stage III Class: 100000004864MedDRA version: 21.1Level: LLTClassification code: 10006188Term: Breast cancer female NOS Class: 10029104MedDRA version: 20.0Level: PTClassification code: 10006200Term: Breast cancer stage II Class: 100000004864MedDRA version: 21.1Level: LLTClassification code: 10006191Term: Breast cancer male NOS Class: 10029104CTIS2023-508411-23-00Karolinska University Hospital200
进行中（未招募）
1 期
PREDIX HER2 - preoperative treatment of HER2 positive breast cancerEUCTR2014-000808-10-SEKarolinska University Hospital200